1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on August 8, 2025

Renal Transplant Therapeutics Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Calcineurin Inhibitors Dominate Renal Transplant Therapeutics Market
SNY

GlobeNewswire

8 hours ago

Renal Transplant Therapeutics Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Calcineurin Inhibitors Dominate Renal Transplant Therapeutics Market

Pneumococcal Disease Pipeline Market Research 2025 | Therapeutic Assessments by Product Type, Stage, Administration Route, and Molecule Type
SNY

GlobeNewswire

8 hours ago

Pneumococcal Disease Pipeline Market Research 2025 | Therapeutic Assessments by Product Type, Stage, Administration Route, and Molecule Type

NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
SNY

Zacks

a day ago

NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
SNY

GlobeNewswire

a day ago

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
SNY

GlobeNewswire

a day ago

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

RFK Jr’s mRNA funding halt signals “shift in US public health”
SNY

Pharmaceutical Technology

a day ago

RFK Jr’s mRNA funding halt signals “shift in US public health”

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
SNY

GlobeNewswire

a day ago

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

SNY

Argus Research

a day ago

Analyst Report: Sanofi SA

SNY

Argus Research

a day ago

Market Digest: SNY, DIS, GPN, ICE, SHEL, SON, SYK, MDLZ, ANET

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
SNY

Zacks

2 days ago

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down

Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
SNY

Benzinga

2 days ago

Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales

SNY

Investing.com

2 days ago

Novavax lifts 2025 revenue outlook after FDA milestone payment

Novavax raises annual revenue forecast on vaccine supply partnerships
SNY

Reuters

2 days ago

Novavax raises annual revenue forecast on vaccine supply partnerships

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
SNY

PR Newswire

2 days ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

SNY

MT Newswires

2 days ago

US Health Department Ending Federal mRNA Vaccine Development

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
SNY

GlobeNewswire

3 days ago

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

SNY

Morningstar Research

3 days ago

Analyst Report: Sanofi

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
SNY

Zacks

3 days ago

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View

Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
SNY

GlobeNewswire

3 days ago

Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update

SNY

Morningstar Research

4 days ago

Analyst Report: BioNTech SE

Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
SNY

Zacks

4 days ago

Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
SNY

Zacks

4 days ago

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

SNY

Morningstar Research

4 days ago

Analyst Report: Regeneron Pharmaceuticals, Inc.

Arrowhead sells China hypertriglyceridemia candidate rights to Sanofi
SNY

Pharmaceutical Technology

4 days ago

Arrowhead sells China hypertriglyceridemia candidate rights to Sanofi

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

7 days ago

Health Care Roundup: Market Talk

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
SNY

Benzinga

7 days ago

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

Regeneron Stock Is Rising on Earnings. This Sanofi Collaboration Is Helping.
SNY

Barrons.com

7 days ago

Regeneron Stock Is Rising on Earnings. This Sanofi Collaboration Is Helping.

BioMarin Announces Appointment of Ian T. Clark to Board of Directors
SNY

PR Newswire

7 days ago

BioMarin Announces Appointment of Ian T. Clark to Board of Directors

Regeneron posts better-than-expected Q2 results, downplays tariff impact
SNY

Reuters

7 days ago

Regeneron posts better-than-expected Q2 results, downplays tariff impact

Reddit, Coinbase, Novo Nordisk - Trending Stocks
SNY

Yahoo Finance Video

7 days ago

Reddit, Coinbase, Novo Nordisk - Trending Stocks

SNY

Investing.com

7 days ago

Regeneron shares edge higher as second quarter earnings surpass estimates

SNY

MT Newswires

7 days ago

Arrowhead Pharmaceuticals Unit Sells China Rights to Plozasiran to Sanofi

Regeneron Reports Second Quarter 2025 Financial and Operating Results
SNY

GlobeNewswire

7 days ago

Regeneron Reports Second Quarter 2025 Financial and Operating Results

SNY

MT Newswires

8 days ago

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

SNY

MT Newswires

8 days ago

Sector Update: Health Care

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
SNY

GlobeNewswire

8 days ago

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas

SNY

MT Newswires

8 days ago

Sanofi Q2 Earnings, Revenue Rise

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
SNY

GlobeNewswire

8 days ago

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA

Sanofi Upbeat on Sales Outlook After Faster-Than-Expected Growth
SNY

The Wall Street Journal

9 days ago

Sanofi Upbeat on Sales Outlook After Faster-Than-Expected Growth

SNY

GlobeNewswire

9 days ago

Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range

Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components
SNY

GlobeNewswire

9 days ago

Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components

Infectious Disease Treatment Market Report 2025-2030 | Long-acting Injectables, Self-testing Kits, and Combination Therapies Fueling Growth
SNY

GlobeNewswire

9 days ago

Infectious Disease Treatment Market Report 2025-2030 | Long-acting Injectables, Self-testing Kits, and Combination Therapies Fueling Growth

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
SNY

GlobeNewswire

10 days ago

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma

SNY

Argus Research

10 days ago

The Argus Min Vol Model Portfolio

SNY

Argus Research

10 days ago

The Argus Min Vol Model Portfolio

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
SNY

Reuters

11 days ago

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

MapLight Therapeutics Announces $372.5 Million Series D Financing
SNY

PR Newswire

11 days ago

MapLight Therapeutics Announces $372.5 Million Series D Financing

SNY

Pharmaceutical Technology

11 days ago

Sanofi’s Sarclisa gains EC approval for multiple myeloma treatment

Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference
SNY

Simply Wall St.

14 days ago

Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference

SNY

MT Newswires

14 days ago

Sanofi's Sarclisa Gets EU Approval for Newly Diagnosed Multiple Myeloma

Regeneron Pharmaceuticals Earnings Preview: What to Expect
SNY

Barchart

14 days ago

Regeneron Pharmaceuticals Earnings Preview: What to Expect

Weekly Recap: 12 Health Press Releases You Need to See
SNY

PR Newswire

14 days ago

Weekly Recap: 12 Health Press Releases You Need to See

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
SNY

GlobeNewswire

15 days ago

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

SNY

Morningstar Research

15 days ago

Analyst Report: Sanofi

C3.ai Expands Beyond Oil: Is Diversification Paying Off?
SNY

Zacks

15 days ago

C3.ai Expands Beyond Oil: Is Diversification Paying Off?

Kling Bio and Sanofi link for antibodies and epitopes discovery
SNY

Pharmaceutical Technology

15 days ago

Kling Bio and Sanofi link for antibodies and epitopes discovery

Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies
SNY

PR Newswire

15 days ago

Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies

Africa Pharmaceuticals Market Analysis, Growth Trends, and Forecast Report 2025-2032 | Urbanization and NCDs Drive Demand, Regulatory Harmonization & Local Production Boost Growth
SNY

GlobeNewswire

16 days ago

Africa Pharmaceuticals Market Analysis, Growth Trends, and Forecast Report 2025-2032 | Urbanization and NCDs Drive Demand, Regulatory Harmonization & Local Production Boost Growth

SNY

MT Newswires

16 days ago

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

Sanofi to acquire Vicebio’s share capital for $1.15bn upfront
SNY

Pharmaceutical Technology

16 days ago

Sanofi to acquire Vicebio’s share capital for $1.15bn upfront

Peptic Ulcer Drugs Market Forecast Report 2025-2034 | FDA Approves New Helicobacter pylori Treatment; Market Growth Expected
SNY

GlobeNewswire

16 days ago

Peptic Ulcer Drugs Market Forecast Report 2025-2034 | FDA Approves New Helicobacter pylori Treatment; Market Growth Expected

Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy
SNY

Benzinga

17 days ago

Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy

SNY

MT Newswires

17 days ago

Sector Update: Health Care Stocks Rise Tuesday Afternoon

SNY

MT Newswires

17 days ago

Sanofi Says Beyfortus RSV Study in Infants Met Endpoints; Shares Rise

SNY

PR Newswire

17 days ago

BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study

Sanofi to acquire vaccine biotech in billion-dollar deal
SNY

BioPharma Dive

17 days ago

Sanofi to acquire vaccine biotech in billion-dollar deal

Sanofi to Buy Vaccine Developer Vicebio for Up to $1.6 Billion
SNY

The Wall Street Journal

17 days ago

Sanofi to Buy Vaccine Developer Vicebio for Up to $1.6 Billion

Billion euro deal: Sanofi buys UK biotech company to expand respiratory vaccine portfolio
SNY

Euronews

17 days ago

Billion euro deal: Sanofi buys UK biotech company to expand respiratory vaccine portfolio

SNY

MT Newswires

17 days ago

Sanofi to Acquire UK Biotech Vicebio for $1.15 Billion to Bolster Respiratory Vaccine Pipeline

Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for US$1.6 billion
SNY

PR Newswire

18 days ago

Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for US$1.6 billion

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
SNY

GlobeNewswire

18 days ago

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline

NYC Council's Firewall Starts in District 5--with a Bombshell Named Alina
SNY

PR Newswire

18 days ago

NYC Council's Firewall Starts in District 5--with a Bombshell Named Alina

Sanofi (SNY) Expands Rare Disease Reach With $9.5B Blueprint Deal
SNY

Insider Monkey

18 days ago

Sanofi (SNY) Expands Rare Disease Reach With $9.5B Blueprint Deal

SNY

MT Newswires

18 days ago

SAB Biotherapeutics Raises $175 Million in Oversubscribed Private Placement; Shares Rise Pre-Bell

Sanofi concludes Blueprint Medicines acquisition
SNY

Pharmaceutical Technology

18 days ago

Sanofi concludes Blueprint Medicines acquisition

SAB BIO Announces Oversubscribed $175 Million Private Placement
SNY

GlobeNewswire

18 days ago

SAB BIO Announces Oversubscribed $175 Million Private Placement

Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi
SNY

Insider Monkey

20 days ago

Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi

Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?
SNY

Zacks

21 days ago

Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?

Adult-onset Still Disease Market Research Report 2025-2035 | Personalized Medicine and Biomarker Discoveries Enhance Treatment Outcomes
SNY

GlobeNewswire

21 days ago

Adult-onset Still Disease Market Research Report 2025-2035 | Personalized Medicine and Biomarker Discoveries Enhance Treatment Outcomes

Fabry Disease Treatment Analysis Report 2025 | Market to Reach $3.86 Billion by 2030, Rising Fabry Disease Prevalence and Demand for Targeted Therapies Drive Growth
SNY

GlobeNewswire

21 days ago

Fabry Disease Treatment Analysis Report 2025 | Market to Reach $3.86 Billion by 2030, Rising Fabry Disease Prevalence and Demand for Targeted Therapies Drive Growth

SNY

MT Newswires

21 days ago

Sanofi Closes Acquisition of Blueprint Medicines

Press Release: Sanofi completes acquisition of Blueprint Medicines
SNY

GlobeNewswire

22 days ago

Press Release: Sanofi completes acquisition of Blueprint Medicines

Trinity Life Sciences Unveils Breakthrough AI Model That Detects Type 1 Diabetes a Year Before Symptoms Appear
SNY

Business Wire

22 days ago

Trinity Life Sciences Unveils Breakthrough AI Model That Detects Type 1 Diabetes a Year Before Symptoms Appear

Thermo Fisher acquires Sanofi’s steriles manufacturing site in US
SNY

Pharmaceutical Technology

22 days ago

Thermo Fisher acquires Sanofi’s steriles manufacturing site in US

Press Release: Sanofi announces extension of Blueprint tender offer
SNY

GlobeNewswire

23 days ago

Press Release: Sanofi announces extension of Blueprint tender offer

Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag
SNY

Zacks

23 days ago

Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
SNY

Zacks

23 days ago

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?

Thermo Fisher acquires Sanofi's New Jersey manufacturing site
SNY

Reuters

23 days ago

Thermo Fisher acquires Sanofi's New Jersey manufacturing site

SNY

MT Newswires

23 days ago

Thermo Fisher, Sanofi Expand Partnership With New Jersey Facility Deal

Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing
SNY

Business Wire

23 days ago

Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing

Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More
SNY

GlobeNewswire

24 days ago

Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More

Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.
SNY

Barrons.com

25 days ago

Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements
SNY

GlobeNewswire

25 days ago

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
SNY

TipRanks

a month ago

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports

SNY

MT Newswires

a month ago

Nurix Therapeutics Fiscal Q2 Loss Narrows, Revenue More Than Triples; Shares Surge Premarket

Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding
SNY

BioPharma Dive

a month ago

Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding

Morgan Stanley Assumes Coverage of Kymera Therapeutics (KYMR) Stock with Overweight Rating
SNY

Insider Monkey

a month ago

Morgan Stanley Assumes Coverage of Kymera Therapeutics (KYMR) Stock with Overweight Rating

CTO East Coast 2025: AI can speed up all parts of clinical trial ecosystem
SNY

Clinical Trials Arena

a month ago

CTO East Coast 2025: AI can speed up all parts of clinical trial ecosystem

Sanofi: Information concerning the total number of voting rights and shares - June 2025
SNY

GlobeNewswire

a month ago

Sanofi: Information concerning the total number of voting rights and shares - June 2025

Stocks to Watch Wednesday: Freeport-McMoRan, UnitedHealth, Novo Nordisk
SNY

The Wall Street Journal

a month ago

Stocks to Watch Wednesday: Freeport-McMoRan, UnitedHealth, Novo Nordisk

Share on Social Networks: